The acquisition will help Zydus expand its animal health business in India and gain access to manufacturing operations which have also been catering to global markets, it said.

The companies, however, did not share financial details of the deal.

As a result of the acquisition, Zydus gains access to a wide range of nutrition as as well as therapeutic products which have strong brand equity and a combine turnover of Rs 171 crore.

A major boost to Zydus's portfolio would be the addition of livestock farmcare products which are well accepted in the market, the company said.

The plant spread over 10,000 square meters manufactures tablets, liquid orals and injectables among others.

Zydus Animal Health is the country's leading animal healthcare player and market leader in various therapeutic segments including antibacterials, antimastitis, tonics and poultry vaccines.

Latest News  from Business News Desk